← Leaderboards
Marianne Ulcickas Yood
Kaiser Foundation Research Institute
$1,508,413
Attributed
$3,349,311
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–13$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$3,349,311 · 2
By mechanism
R01$2,351,858 · 1
RC1$997,453 · 1
Top collaborators
- Christine C Johnson4 shared
- Arnold L Potosky2 shared
- Stephen K. Van Den Eeden2 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Jaejin An$4,582,632
- Yiyi Zhang$4,582,632
- Andrew John Karter$16,048,581
- Stephen K. Van Den Eeden$13,042,835
- Julie A Schmittdiel$8,595,565
Others in their field
Top investigators on “S Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
S LymphomaHealth SystemDiagnosisStagingPublic Health Medicine (Field)Malignant NeoplasmsHigh RiskPharmacy FacilitySerious Adverse EventDatabasesRisk FactorsCohortCostBenefits And RisksPrevalenceAtorvastatinConflict (Psychology)ApoptosisChronic Lymphocytic LeukemiaCollaborationsCell Cycle ProgressionAntilipemic AgentsChemopreventionAffect
Grant awards (6)
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort$523,362
R01 · FY2013 · CA
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort$561,236
R01 · FY2012 · CA
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort$574,828
R01 · FY2011 · CA
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort$692,432
R01 · FY2010 · CA
Cost-Effectiveness of Hormonal Therapy for Clinically Localized Prostate Cancer$497,496
RC1 · FY2010 · CA
Cost-Effectiveness of Hormonal Therapy for Clinically Localized Prostate Cancer$499,957
RC1 · FY2009 · CA